MSME Pharma firms warn of rising compliance burden as regulatory costs surge: FOPE Study
India’s MSME pharmaceutical manufacturers are facing mounting financial and operational pressure due to recent regulatory reforms,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
MSME
TDB backs Nitika Pharmaceutical Specialties for domestic production of complex excipients
DST’s Technology Development Board extends financial support to Nagpur-based Nitika for manufacturing 14 advanced excipients under…
Sanjaya Mariwala highlights key takeaways from Union Budget 2025
Mariwala, shares his insights on the Union Budget 2025, highlighting its impact on economic growth, MSMEs, healthcare, and skill…
MoHFW announces revised Schedule M under the Drugs (Amendment) Rules, 2023
Small and medium manufacturers with an annual turnover of less than Rs 250 crore have 12 months to comply with the guidelines,…
Digital roadmap defines the success of technology initiatives
Amit Saluja, Senior Director and Head, NASSCOM CoE, explains the role of technology in pharma manufacturing, while also shedding…
Government earmarks Rs 500 crores for scheme to support pharma clusters and MSMEs
The objectives of the scheme are to strengthen the existing infrastructure facilities to make India a global leader in the pharma…
Minister of Chemicals and Fertilisers encourages industry to avail Phase II PLI scheme benefits
The scheme will be designed to benefit MSMEs along with large players
Ministry of MSME, GoI partners with Telangana Government for BioAsia 2020
Given that the MSMEs contribute to over 80 per cent of the Indian Lifesciences industry and has been an important pillar for the…